Corbus Pharmaceuticals Holdings, Inc. (CRBP) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -25.57M | -15.92M | -15.55M | -16.6M | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M | -6.01M | -7.18M | -7.8M | -15.11M | -7.45M | -7.25M | -12.23M | -10.62M | -9.7M | 856.95K | -17.53M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 880.53% | -12835.99% |
| Operating CF Growth % | -55.72% | -45.5% | -11.53% | -85.61% | -106.1% | -82.1% | -94.29% | -14.65% | 47.29% | 19.4% | 0.95% | 36.22% | -42.39% | 23.16% | -945.44% | 30.23% | 51.33% | 46.76% | 103.14% | 34.12% |
| Net Income | -22.97M | -20.55M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M |
| Depreciation & Amortization | 0 | -439K | 50K | 53K | 81K | 146K | 102.31K | 282K | 151.69K | 147.58K | 153K | 158.34K | 181.87K | 374.22K | 190.79K | 192.08K | 195.72K | 375.15K | 307.98K | 420.94K |
| Stock-Based Compensation | 0 | 1.43M | 1.58M | 1.56M | 1.71M | 0 | 2.24M | 1.29M | 0 | 799.18K | 821K | 0 | 1.03M | 1.27M | 1.35M | 1.51M | 1.59M | 1.79M | 2.6M | 2.51M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.7M | -191K | -3K | -675K | -238K | 992K | -476.31K | -1.9M | 266.6K | 76.88K | 72K | 778.56K | -2.14K | -182.63K | 11.14K | 801.12K | 988.86K | 712.02K | 1.19M | 130.84K |
| Working Capital Changes | -4.3M | 3.83M | 6.16M | 122K | -1M | -2.55M | -2.03M | 1.38M | -1.49M | 988.88K | 1.83M | 46.67K | 1.42M | 1.96M | -10.79K | -1.49M | -3.95M | -2.32M | -1.07M | -3.45M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5M | -97.32K | -136.56K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.87M | -564K | -1.28M | 175K | -684K | 1.68M | 1.95M | 0 | -1.13M | -1.5M | 3.19M | 184.21K | -848.06K | 980.46K | -810.43K | -992.18K | 565.31K | -759.71K | 237.52K | -1.74M |
| Cash from Investing | 22.45M | -57.15M | 19.64M | 17.74M | 18.12M | 8.73M | -15.37M | -16.44M | -98.24M | 10.39M | 10.9M | 8.81M | 5.55M | 11.78M | -5.97M | -18.7M | 42.96M | -3.18M | 284.1K | -13.1M |
| Capital Expenditures | -6K | -7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.45K | -54.17K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.2K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.1K | 0 | 0 | 1.3K | 3.8K |
| Cash from Financing | 0 | 74.58M | 2.85M | 0 | 0 | -13K | 25.04M | 34.97M | 106.58M | -1.9M | -821K | 17.69K | -113.01K | 234.32K | -110.7K | -330.11K | -327.13K | 767.94K | -102.69K | -255.59K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -10.9M | -2.15M | -2.32M | -1.83M | -741K | -152.1K | -150.07K | 234.32K | -110.7K | -330.11K | -327.13K | 767.94K | -102.69K | -305.58K |
| Equity Issued (Net) | 0 | 74.58M | 2.85M | 0 | 0 | -13K | 35.94M | 0 | 108.9M | 197 | -80K | 169.79K | 37.06K | 0 | 0 | 0 | 0 | 0 | 0 | 50K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.12M | 0 | -73.84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -3.12M | 1.51M | 6.94M | 1.14M | 1.7M | -2.23M | -4.26M | 9.58M | 471.91K | 2.47M | 2.9M | 1.02M | -9.68M | 4.56M | -13.33M | -31.26M | 32.02M | -12.11M | 1.04M | -30.88M |
| Free Cash Flow | -25.58M | -15.93M | -15.55M | -16.6M | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M | -6.01M | -7.18M | -7.8M | -15.11M | -7.45M | -7.25M | -12.23M | -10.63M | -9.76M | 856.95K | -17.53M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 880.53% | -12835.99% |
| FCF Growth % | -55.76% | -45.57% | -11.53% | -85.61% | -106.1% | -82.1% | -94.29% | -14.65% | 47.29% | 19.4% | 0.95% | 36.22% | -42.21% | 23.59% | -945.44% | 30.23% | 51.27% | 46.31% | 103.14% | 34.16% |
| FCF per Share | -1.92 | -1.20 | -1.26 | -1.36 | -1.35 | -0.90 | -1.16 | -3.18 | -2.83 | -1.36 | -1.62 | -1.82 | -3.61 | -1.79 | -1.74 | -2.93 | -2.55 | -2.34 | 0.21 | -4.52 |
| FCF Conversion (FCF/Net Income) | 1.11x | 0.77x | 0.67x | 0.94x | 0.97x | 1.15x | 1.01x | 0.89x | 1.15x | 0.75x | 0.71x | 0.89x | 0.85x | 0.69x | 0.83x | 0.92x | 1.12x | 0.95x | -0.39x | 1.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 437K | 0 | 621.08K | 664K | 0 | 641.46K | 0 | 519.78K | 456.43K | 431K | 0 | 434.86K | 438.19K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |